Altered baroreflex gain during voluntary breathing in chronic heart failure.

Mangin L, Monti A, Medigue C, Macquin-Mavier I, Lopes M, Gueret P, Castaigne A, Swynghedauw B, Mansier P.
Eur J Heart Fail. 2001 Mar;3(2):189-95.
 

Converting enzyme inhibition normalizes QT interval in spontaneously hypertensive rats.

Baillard C, Mansier P, Ennezat PV, Mangin L, Medigue C, Swynghedauw B, Chevalier B.
Hypertension. 2000 Sep;36(3):350-4.
 

1999

Physiologie, une science qui se réveille

Swynghedauw B, Mansier P.
Médecine/Sciences 1999 ; 15: 868-872.
 

1998

Functional coupling of overexpressed beta 1-adrenoceptors in the myocardium of transgenic mice.

Zolk O, Kilter H, Flesch M, Mansier P, Swynghedauw B, Schnabel P, Bohm M.
Biochem Biophys Res Commun. 1998 Jul 30;248(3):801-5.
 

1997

Myocardial determinants in regulation of the heart rate.

Swynghedauw B, Jasson S, Clairambault J, Chevalier B, Heymes C, Medigue C, Carre F, Mansier P.
J Mol Med. 1997 Nov-Dec;75(11-12):860-6. Review.

Instant power spectrum analysis of heart rate variability during orthostatic tilt using a time-/frequency-domain method.

Jasson S, Medigue C, Maison-Blanche P, Montano N, Meyer L, Vermeiren C, Mansier P, Coumel P, Malliani A, Swynghedauw B.
Circulation. 1997 Nov 18;96(10):3521-6.

Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process.

Swynghedauw B, Chevalier B, Charlemagne D, Mansier P, Carre F.
Cardiovasc Res. 1997 Jul;35(1):6-12. Review.

Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis.

Assayag P, Carre F, Chevalier B, Delcayre C, Mansier P, Swynghedauw B.
Cardiovasc Res. 1997 Jun;34(3):439-44. Review.

A statistical analysis of sequences of cardiac interbeat intervals does not support the chaos hypothesis.

Le Pape G, Giacomini H, Swynghedauw B, Mansier P.
J Theor Biol. 1997 Jan 21;184(2):123-31.

beta-Adrenergic and muscarinic receptor expression are regulated in opposite ways during senescence in rat left ventricle.

Hardouin S, Mansier P, Bertin B, Dakhly T, Swynghedauw B, Moalic JM.
J Mol Cell Cardiol. 1997 Jan;29(1):309-19.

Heart rate and heart rate variability, a pharmacological target.

Swynghedauw B, Jasson S, Chevalier B, Clairambault J, Hardouin S, Heymes C, Mangin L, Mansier P, Medigue C, Moalic JM, Thibault N, Carre F.
Cardiovasc Drugs Ther. 1997;10(6), 677-85.
 

1996

Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors.

Mansier P, Medigue C, Charlotte N, Vermeiren C, Coraboeuf E, Deroubai E, Ratner E, Chevalier B, Clairambault J, Carre F, Dahkli T, Bertin B, Briand P, Strosberg D, Swynghedauw B.
Am J Physiol. 1996 Oct;271(4 Pt 2):H1465-72.

Linear and non-linear analyses of heart rate variability: a minireview.

Mansier P, Clairambault J, Charlotte N, Medigue C, Vermeiren C, LePape G, Carre F, Gounaropoulou A, Swynghedauw B.
Cardiovasc Res. 1996 Mar;31(3):371-9. Review.
 

1994

Phenotypic determinants of heart rate variability in cardiac hypertrophy and failure.

Carre F, Maison-Blanche P, Mansier P, Chevalier B, Charlotte N, Dakhli T, Coumel P, Swynghedauw B.
Eur Heart J. 1994 Dec;15 Suppl D:58-62.

Heart rate variability in two models of cardiac hypertrophy in rats in relation to the new molecular phenotype.

Carre F, Maison-Blanche P, Ollivier L, Mansier P, Chevalier B, Vicuna R, Lessard Y, Coumel P, Swynghedauw B.
Am J Physiol. 1994 May;266(5 Pt 2):H1872-8.
 

1993

Specific atrial overexpression of G protein coupled human beta 1 adrenoceptors in transgenic mice.

Bertin B, Mansier P, Makeh I, Briand P, Rostene W, Swynghedauw B, Strosberg AD.
Cardiovasc Res. 1993 Sep;27(9):1606-12.

Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat.

Mansier P, Chevalier B, Barnett DB, Swynghedauw B.
Pflugers Arch. 1993 Aug;424(3-4):354-60.

Cardiac hypertrophy and failure--a disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity.

Moalic JM, Charlemagne D, Mansier P, Chevalier B, Swynghedauw B.
Circulation. 1993 May;87(5 Suppl):IV21-6. Review.

Triiodothyronine therapy in open-heart surgery: from hope to disappointment.

Teiger E, Menasche P, Mansier P, Chevalier B, Lajeunie E, Bloch G, Piwnica A.
Eur Heart J. 1993 May;14(5):629-33.

Beta 1 adrenergic receptor and G alpha s mRNAs in rat heart as a function of mechanical load and thyroxine intoxication.

Moalic JM, Bourgeois F, Mansier P, Machida CA, Carre F, Chevalier B, Pitarque P, Swynghedauw B.
Cardiovasc Res. 1993 Feb;27(2):231-7.
 

1992

Remodeling of the heart (membrane proteins and collagen) in hypertensive cardiopathy.

Sainte Beuve C, Leclercq C, Rannou F, Oliviero P, Mansier P, Chevalier B, Swynghedauw B, Charlemagne D.
Kidney Int Suppl. 1992 Jun;37:S45-50. Review.

The membrane proteins of the overloaded and senescent heart.

Chevalier B, Charlemagne D, Callens-el Amrani F, Carre F, Moalic JM, Delcayre C, Mansier P, Swynghedauw B.
Basic Res Cardiol. 1992;87 Suppl 1:187-97. Review.
 

1991

Alterations in beta adrenergic and muscarinic receptors in aged rat heart. Effects of chronic administration of propranolol and atropine.

Chevalier B, Mansier P, Teiger E, Callen-el Amrani F, Swynghedauw B.
Mech Ageing Dev. 1991 Oct;60(2):215-24.

Membrane proteins of the myocytes in cardiac overload.

: Mansier P, Chevalier B, Mayoux E, Charlemagne D, Ollivier L, Callens-el Amrani F, Swynghedauw B.
Acta Cardiol. 1991;46(3):299-307.
 

1990

Membrane proteins of the myocytes in cardiac overload.

Mansier P, Chevalier B, Mayoux E, Charlemagne D, Ollivier L, Callens-el Amrani F, Swynghedauw B.
Br J Clin Pharmacol. 1990;30 Suppl 1:43S-48S.
 

1989

Signal and adaptational changes in gene expression during cardiac overload.

Chevalier B, Callens F, Charlemagne D, Delcayre C, Lompre AM, Lelievre L, Mercadier JJ, Moalic JM, Mansier P, Rappaport L, et al.
J Mol Cell Cardiol. 1989 Dec;21 Suppl 5:71-7. Review.

Beta-adrenergic system is modified in compensatory pressure cardiac overload in rats: physiological and biochemical evidence.

Chevalier B, Mansier P, Callens-el Amrani F, Swynghedauw B.
J Cardiovasc Pharmacol. 1989 Mar;13(3):412-20.
 

1987

Screening of inotropic drugs on isolated rat and guinea pig hearts.

Chevalier B, Mouas C, Mansier P, Aumont MC, Swynghedauw B.
J Pharmacol Methods. 1987 Jul;17(4):313-26.
 

1984

Hypertrophied rat heart. New Na+, K+-ATPase-ouabain interactions in sarcolemma vesicles.

Charlemagne D, Mansier P, Preteseille M, Swynghedauw B, Lelievre LG.
Eur Heart J. 1984 Dec;5 Suppl F:315-21.

Effects of calcium on the heterogeneity of the Na+, K+-ATPase forms in rat heart.

Lelievre LG, Mansier P, Charlemagne D, Swynghedauw B.
Basic Res Cardiol. 1984;79 Suppl:128-33.
 

1983

Isolation of impermeable inside-out vesicles from an enriched sarcolemma fraction of rat heart.

Mansier P, Charlemagne D, Rossi B, Preteseille M, Swynghedauw B, Lelievre L.
J Biol Chem. 1983 May 25;258(10):6628-35.

Three Na+, K+-ATPase forms in rat heart as revealed by K+/ouabain antagonism.

Mansier P, Cassidy PS, Charlemagne D, Preteseille M, Lelievre LG.
FEBS Lett. 1983 Mar 21;153(2):357-60.
 

1982

CA2+-free perfusion of rat heart reveals a (Na+ + K+)ATPase form highly sensitive to ouabain.

Mansier P, Lelievre LG.
Nature. 1982 Dec 9;300(5892):535-7.